Will the EPO’s Enlarged Board of Appeal hear the Broad's CRISPR case?
Research output: Contribution to journal › Journal article › Research › peer-review
As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal.
|Journal||Life Sciences Intellectual Property Review (LSIPR)|
|Issue number||13/7 2018|
|Number of pages||6|
|Publication status||Published - 13 Jul 2018|
- Faculty of Law - patents gene editing, CRISPR-Cas 9, European Patent Office, Appeal, Broad Institute